Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Certara, Inc. (NASDAQ:CERT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $15.17.

Several research firms have recently weighed in on CERT. Stephens reissued an "overweight" rating and issued a $17.00 target price on shares of Certara in a research report on Thursday, February 27th. Barclays reduced their target price on Certara from $13.00 to $11.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. Robert W. Baird boosted their price target on shares of Certara from $9.00 to $13.00 and gave the company a "neutral" rating in a report on Friday, April 11th. KeyCorp lifted their price objective on shares of Certara from $15.00 to $18.00 and gave the company an "overweight" rating in a research report on Wednesday. Finally, William Blair reiterated a "market perform" rating on shares of Certara in a research report on Thursday, February 27th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of CERT. Kopion Asset Management LLC raised its holdings in shares of Certara by 46.0% in the fourth quarter. Kopion Asset Management LLC now owns 555,643 shares of the company's stock valued at $5,918,000 after buying an additional 175,005 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Certara by 3.1% during the 4th quarter. Principal Financial Group Inc. now owns 531,445 shares of the company's stock worth $5,660,000 after purchasing an additional 15,739 shares during the last quarter. Vontobel Holding Ltd. acquired a new position in Certara during the 4th quarter valued at about $1,295,000. Barclays PLC boosted its stake in shares of Certara by 198.3% in the 3rd quarter. Barclays PLC now owns 70,525 shares of the company's stock valued at $825,000 after purchasing an additional 46,880 shares during the last quarter. Finally, Proficio Capital Partners LLC acquired a new stake in shares of Certara during the 4th quarter worth approximately $148,000. 73.96% of the stock is owned by institutional investors and hedge funds.

Certara Stock Up 4.6 %

NASDAQ CERT traded up $0.62 on Friday, reaching $14.15. The company had a trading volume of 2,114,112 shares, compared to its average volume of 1,188,632. The firm has a market capitalization of $2.28 billion, a PE ratio of -70.75, a P/E/G ratio of 9.29 and a beta of 1.64. The firm has a 50-day moving average of $11.62 and a 200-day moving average of $11.46. Certara has a 1 year low of $8.64 and a 1 year high of $17.94. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.